HS-20106

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-20106, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes [Phase 2]

See pricing